These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 31262399

  • 1. Membranous nephropathy and thrombotic microangiopathy secondary to metastatic prostate cancer after Iodine-125 prostate brachytherapy: A case report
.
    Yang L, Liang D, Cheng S, Ge Y.
    Clin Nephrol; 2019 Sep; 92(3):155-158. PubMed ID: 31262399
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Primary Membranous Nephropathy.
    Couser WG.
    Clin J Am Soc Nephrol; 2017 Jun 07; 12(6):983-997. PubMed ID: 28550082
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recurrent membranous nephropathy with a possible alteration in the etiology: a case report.
    Matsumoto A, Matsui I, Mano K, Mizuno H, Katsuma Y, Yasuda S, Shimada K, Inoue K, Oki T, Hanai T, Kojima K, Kaneko T, Isaka Y.
    BMC Nephrol; 2021 Jul 06; 22(1):253. PubMed ID: 34229600
    [Abstract] [Full Text] [Related]

  • 6. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy.
    Hoxha E, Harendza S, Pinnschmidt HO, Tomas NM, Helmchen U, Panzer U, Stahl RA.
    Nephrol Dial Transplant; 2015 Nov 06; 30(11):1862-9. PubMed ID: 26142398
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia.
    Shirai S, Akiyama S, Kamijo-Ikemori A, Suzuki T, Ichikawa D, Koike J, Kimura K, Shibagaki Y.
    CEN Case Rep; 2020 Feb 06; 9(1):65-73. PubMed ID: 31705303
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of M-type phospholipase A2 receptor and thrombospondin Type 1 domain-containing 7A in primary membranous nephropathy.
    Gong Z, Yuan S, Zhu X, Wang Y, Yu F, Yang D, Xu X, Liu H, Li J, Sun L.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jun 28; 45(6):693-700. PubMed ID: 32879127
    [Abstract] [Full Text] [Related]

  • 10. Clinical and Histological Features of Phospholipase A2 Receptor-Associated and Thrombospondin Type-I Domain-containing 7A-Associated Idiopathic Membranous Nephropathy: A Single Center Retrospective Study from China.
    Zhang D, Zou J, Zhang C, Zhang W, Lin F, Jiang G.
    Med Sci Monit; 2018 Jul 22; 24():5076-5083. PubMed ID: 30032157
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy.
    Iwakura T, Ohashi N, Kato A, Baba S, Yasuda H.
    PLoS One; 2015 Jul 22; 10(9):e0138841. PubMed ID: 26393352
    [Abstract] [Full Text] [Related]

  • 12. Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain.
    L'Imperio V, Pieruzzi F, Sinico RA, Nebuloni M, Granata A, Smith A, Radice A, Pagni F.
    J Nephrol; 2018 Aug 22; 31(4):543-550. PubMed ID: 29626294
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy.
    Zaghrini C, Seitz-Polski B, Justino J, Dolla G, Payré C, Jourde-Chiche N, Van de Logt AE, Booth C, Rigby E, Lonnbro-Widgren J, Nystrom J, Mariat C, Cui Z, Wetzels JFM, Ghiggeri G, Beck LH, Ronco P, Debiec H, Lambeau G.
    Kidney Int; 2019 Mar 22; 95(3):666-679. PubMed ID: 30784662
    [Abstract] [Full Text] [Related]

  • 15. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy.
    Tomas NM, Hoxha E, Reinicke AT, Fester L, Helmchen U, Gerth J, Bachmann F, Budde K, Koch-Nolte F, Zahner G, Rune G, Lambeau G, Meyer-Schwesinger C, Stahl RA.
    J Clin Invest; 2016 Jul 01; 126(7):2519-32. PubMed ID: 27214550
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma.
    Ratanasrimetha P, Reddy VD, Kala J, Tchakarov A, Glass WF, Msaouel P, Lin JS.
    Front Immunol; 2022 Jul 01; 13():898811. PubMed ID: 35967405
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.